FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Tyme Technologies Inc. Receives Patent Notification for Metabolomic Technology Platform”
Tyme Technologies Inc (NASDAQ: TYME) surged over 54% in premarket trading after the company received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Company’s metabolomic technology platform.
The patent is based on technology developed by Tyme by which the tyrosine isomer racemetyrosine can be fused with a second therapeutic agent in a manner that creates a fusion compound that may allow targeted delivery to the cancer cells in a novel manner.
Tyme is an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™) that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.
For more information, please visit: Tyme Technologies Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.